CLEC12A and malignant colon neoplasm: KLRL1-AS1 (ENSG00000245648) and CASC19 (ENSG00000254166), both down-regulated, exhibit atypical expression patterns in colon cancer, indicating significant roles in its pathology (Table 2 and Fig. 4A).